SAB BIOTHERAPEUTICS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
SAB BIOTHERAPEUTICS, INC. (SABS) had Deferred Tax Liabilities, Property, Plant and Equipment of $1.16 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-03-09
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.16M.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.70M.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $2.58M.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $3.24M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $1.16M 10-K · filed 2026-03-09 |
| 2024-12-31 | $1.70M 10-K · filed 2026-03-09 |
| 2023-12-31 | $2.58M 10-K · filed 2025-03-31 |
| 2022-12-31 | $3.24M 10-K · filed 2024-03-29 |
| 2021-12-31 | $2.52M 10-K · filed 2023-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |